Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
John B. Henneman IIIDirector | Anika TherapeuticsANIK | Open-market buy | 05/01 | 05/04 | 5,000 sh | $14.66 | $73,300 | +10.0% |
Stephen D. GriffinPresident and CEO | Anika TherapeuticsANIK | Open-market buy | 04/30 | 04/30 | 12,200 sh | $12.29 | $149,938 | +50.9% |